Rock Springs Capital Management LP Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$1.2B
Holdings
127
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (127 positions)
| Stock | Value |
|---|---|
—AETNA INC NEW | $46.2M |
—ALLERGAN PLC | $45.8M |
ACHCACADIA HEALTHCARE COMPANY IN | $41.3M |
HCAHCA HOLDINGS INC | $33.6M |
—BAXALTA INC | $32.7M |
ALXNALEXION PHARMACEUTICALS INC | $31.7M |
PFEPFIZER INC | $30.8M |
GILDGILEAD SCIENCES INC | $30.3M |
—ADVANCED ACCELERATOR APPLIC | $29.2M |
—RADIUS HEALTH INC | $25.4M |
ISRGINTUITIVE SURGICAL INC | $25.2M |
CELGCELGENE CORP | $24.0M |
WCGEURWELLCARE HEALTH PLANS INC | $21.3M |
TEVATEVA PHARMACEUTICAL INDS LTD | $21.1M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $20.8M |
—MEDICINES CO | $20.1M |
LLYLILLY ELI & CO | $19.9M |
PCRXPACIRA PHARMACEUTICALS INC | $17.3M |
—SPARK THERAPEUTICS INC | $17.1M |
ACRSACLARIS THERAPEUTICS INC | $17.0M |
ELVANTHEM INC | $16.8M |
CICIGNA CORPORATION | $16.7M |
—TESARO INC | $16.7M |
NBIXNEUROCRINE BIOSCIENCES INC | $16.0M |
TMOTHERMO FISHER SCIENTIFIC INC | $14.2M |
AMGNAMGEN INC | $14.1M |
BIIBBIOGEN INC | $13.8M |
PRTAPROTHENA CORP PLC | $12.7M |
MDMEDNAX INC | $12.6M |
TBPHTHERAVANCE BIOPHARMA INC | $12.2M |
MCKMCKESSON CORP | $12.2M |
JAZZJAZZ PHARMACEUTICALS PLC | $11.2M |
BMYBRISTOL MYERS SQUIBB CO | $10.9M |
PRAHPRA HEALTH SCIENCES INC | $10.8M |
—GW PHARMACEUTICALS PLC | $10.6M |
PENPENUMBRA INC | $10.5M |
WBAWALGREENS BOOTS ALLIANCE INC | $10.4M |
—THERAPEUTICSMD INC | $10.1M |
—ANACOR PHARMACEUTICALS INC | $9.5M |
INCYINCYTE CORP | $9.5M |
—ACHILLION PHARMACEUTICALS IN | $9.4M |
GLPGGALAPAGOS NV | $8.8M |
BMRNBIOMARIN PHARMACEUTICAL INC | $8.5M |
ARDXARDELYX INC | $8.2M |
—WRIGHT MED GROUP N V | $8.1M |
—INOVALON HLDGS INC | $7.9M |
—HEALTHSOUTH CORP | $7.8M |
NVTA1EURINVITAE CORP | $7.7M |
—JUNO THERAPEUTICS INC | $7.5M |
RAREULTRAGENYX PHARMACEUTICAL IN | $7.5M |
—RTI SURGICAL INC | $7.4M |
COOCOOPER COS INC | $7.3M |
—EPIZYME INC | $7.1M |
—RETROPHIN INC | $7.1M |
MCRB1EURSERES THERAPEUTICS INC | $7.0M |
EWEDWARDS LIFESCIENCES CORP | $6.7M |
VRTXVERTEX PHARMACEUTICALS INC | $6.7M |
ALKSALKERMES PLC | $6.7M |
CRVSCORVUS PHARMACEUTICALS INC | $6.6M |
ONCBEIGENE LTD | $6.6M |
—INTERSECT ENT INC | $6.5M |
—ATHENAHEALTH INC | $6.3M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $6.2M |
—NOVADAQ TECHNOLOGIES INC | $6.2M |
—HEARTWARE INTL INC | $6.1M |
—DERMIRA INC | $6.0M |
CHRSCOHERUS BIOSCIENCES INC | $6.0M |
REGNREGENERON PHARMACEUTICALS | $5.9M |
—FIVE PRIME THERAPEUTICS INC | $5.9M |
INSYEURINSYS THERAPEUTICS INC NEW | $5.8M |
IM8NINSMED INC | $5.7M |
—ENVISION HEALTHCARE HLDGS IN | $5.4M |
—CHINA CORD BLOOD CORP | $5.3M |
—ADURO BIOTECH INC | $5.3M |
ITCIEURINTRA CELLULAR THERAPIES INC | $5.2M |
AM6AMICUS THERAPEUTICS INC | $5.2M |
ASNDASCENDIS PHARMA A S | $5.0M |
—XENOPORT INC | $5.0M |
—TANDEM DIABETES CARE INC | $4.9M |
—CARDIOME PHARMA CORP | $4.9M |
—ALLERGAN PLC | $4.6M |
CGENCOMPUGEN LTD | $4.6M |
—PROTEOSTASIS THERAPEUTICS IN | $4.5M |
—CHIASMA INC | $4.5M |
NVAXNOVAVAX INC | $4.4M |
FGENEURFIBROGEN INC | $4.3M |
—PORTOLA PHARMACEUTICALS INC | $4.3M |
MGNXMACROGENICS INC | $4.2M |
—AIMMUNE THERAPEUTICS INC | $4.0M |
—AVEXIS INC | $3.9M |
PRGOPERRIGO CO PLC | $3.8M |
—GENOCEA BIOSCIENCES INC | $3.7M |
—KITE PHARMA INC | $3.7M |
OTICEUROTONOMY INC | $3.6M |
—NABRIVA THERAPEUTICS AG | $3.4M |
—MEDICINES CO | $3.4M |
—PARATEK PHARMACEUTICALS INC | $3.4M |
—CIDARA THERAPEUTICS INC | $3.2M |
DVAXDYNAVAX TECHNOLOGIES CORP | $3.2M |
NVCRNOVOCURE LTD | $3.1M |
Page 1 of 2Next